Structure and basic activities of a consultation unit on metabolic disorders within the programme for prevention of coronary heart disease
Szybínski, Z.; Sznajd, J.; Sieradzki, J.; Magdoń, M.; Mruk, K.; Olszanecki, S.
Przeglad Lekarski 33(6): 579-582
1976
ISSN/ISBN: 0033-2240 PMID: 959606 Document Number: 108573
Document emailed within 1 workday
Related Documents
Sieradzki, J.; Huszno, B.; Mruk, K.; Magdoń, M.; Szybiński, Z. 1976: Questionnaire polling in evaluation of diet utilized in programme for prevention of coronary heart disease Przeglad Lekarski 33(6): 594-598Muñoz, M.A.; Subirana, I.; Ramos, R.; Franzi, A.; Vila, J.; Marrugat, J. 2008: Efficacy of an intensive prevention programme of coronary heart disease: 5 year follow-up outcomes Medicina Clinica 130(14): 521-525
Gilbert, J.C. 1975: Basic treatment of hemodynamic and metabolic disorders in cardiovascular disease Semaine des Hopitaux. Therapeutique 51(9): 463-466
Zhang, H.; Jiang, Y.; Nguyen, H.D.; Poo, D.Chiang.Choon.; Wang, W. 2017: The effect of a smartphone-based coronary heart disease prevention (SBCHDP) programme on awareness and knowledge of CHD, stress, and cardiac-related lifestyle behaviours among the working population in Singapore: a pilot randomised controlled trial Health and Quality of Life Outcomes 15(1): 49
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Haffner, S.M. 2002: Metabolic syndrome, diabetes and coronary heart disease International Journal of Clinical Practice. Suppl 132: 31-37
Vecherskiĭ, G.A. 1978: Hormonal and metabolic disorders in ischemic heart disease Kardiologiia 18(12): 36-40
Medvedeva, I.V.; Dorodneva, E.F.; Pugacheva, T.A.; Belokorylova, L.V.; Shorokhova, T.D.; Ushakova, M.A. 2002: Analysis of lipid plasma spectrum and basic parameters of red cell membranes in patients with metabolic syndrome and ischemic heart disease Klinicheskaia Meditsina 80(5): 27-30
Kratnov, A.E.; Khabarova, I.V. 2009: Neutrophilic intracellular metabolic changes and fatal outcome in coronary heart disease Klinicheskaia Laboratornaia Diagnostika 1: 20-22
Lu, G.; Ouyang, S.; Pei, Z. 1999: Changes of erythrocyte membrane ATPase activities and plasma lipids in patients with coronary heart disease Hunan Yi Ke da Xue Xue Bao 24(1): 68-70
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Gong, X.; Pan, X.; Chen, X.; Hong, C.; Hong, J.; Shen, F. 2012: Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status Journal of International Medical Research 40(3): 934-942
Heinzl, S. 1991: Coronary heart disease and disorders of left ventricular function Medizinische Monatsschrift für Pharmazeuten 14(12): 367-369
Lindberg, E.; Boman, G. 2002: Ask the patient about snoring and daytime sleepiness. Connection between sleep apnea syndrome and heart disease--metabolic disorders Lakartidningen 99(45): 4458-4460
Scott, R.S.; Lintott, C.J.; Bremer, J.; Nye, E.R. 1987: Hyperlipidaemia and the prevention of coronary heart disease New Zealand Medical Journal 100(836): 717-719
Samani, N.J.; de Bono, D.P. 1996: Prevention of coronary heart disease with pravastatin New England Journal of Medicine 334(20): 1333-1334; Author Reply 1334-1335
Singh, R.B.; Niaz, M.A. 1994: Prevention of coronary heart disease in Indians Journal of the Association of Physicians of India 42(7): 545-548
Hloucal, L.; Dusek, J. 1972: Etiopathogenesis and prevention of coronary heart disease Acta Universitatis Carolinae. Medica 18(5-6): 203-227
Butler, R.M.; Goldberg, L. 1989: Exercise and prevention of coronary heart disease Primary Care 16(1): 99-114
Erkkilä, A.T.; Lindi, V.; Lehto, S.; Pyörälä, K.; Laakso, M.; Uusitupa, M.I.J. 2002: Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease Nutrition Metabolism and Cardiovascular Diseases: Nmcd 12(2): 53-59